focus -WSS

focus

author：comprehensive 2025-09-30 21:22:40 - browse：89

Jacob S. Van Naarden (left), Athena Countouriotis( center), and Vlad Coric (right) on stage at the 2023 STAT Summit. — From left, Eli Lilly's Jacob S. Van Naarden, Avenzo's Athena Countouriotis, and Biohaven's Vlad Coric on stage at the 2023 STAT Summit. STAT

What does it feel like to run a biotech startup and then get “the call” — the one from the big pharma CEO who wants to acquire your company for billions of dollars?

At the 2023 STAT Summit on Wednesday, senior biotech writer Adam Feuerstein posed this question to three people very qualified to answer it: Vlad Coric, chairman and CEO of Biohaven, which was acquired by Pfizer in 2022 for $11.6 billion; Jacob Van Naarden, former COO of Loxo Oncology, which was acquired by Eli Lilly (where Van Naarden is now executive vice president) for $8 billion in 2019; and Athena Countouriotis, whose company Turning Point Therapeutics was acquired by BMS for $4 billion in 2022.

“Imagine you’re going through your typical day, and you get a message: Albert Bourla, chairman and CEO of Pfizer, wants to talk at six o’clock tonight,” said Coric, whose company had a successful migraine drug on the market and had just completed an IPO at the time.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Questions loom on AstraZeneca cancer drug as safety concerns ebb

WSS

Study on Amgen’s bispecific immunotherapy produces positive data

There’s a way to spot data fakery. All journals should be using it

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Why a market frenzy over new weight loss drugs defies logic

J&J lung cancer data amount to new salvo against AstraZeneca

Smaller biotechs seek to piggyback on weight loss drug boom

Wikipedia

focus

knowledge

In Memoriam: Notable people who died in 2023

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

In rare move, senator releases unverified FBI source report alleging Biden bribe

Malaria cases in Florida and Texas: Here’s what you need to know

The problems with dementia villages

George Santos makes 1st court appearance after pleading not guilty to 13 counts

STAT Readout Newsletter: Biotech news today

Moonlake's readout produced a cash windfall. Risks remain

STAT Summit: Ending the crisis of Black deaths in the U.S.

explore

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Dementia risk linked to living in disadvantaged areas: Study

Telehealth startups are trying to fill the menopause care vacuum

Roche acquires Telavant from Roivant, adding experimental IBD treatment

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Is there really a nursing shortage in the U.S.?

leisure time

Wikipedia

knowledge

leisure time